SKB BIO-B(06990): The China Securities Regulatory Commission has issued a filing notice for the company's H shares to be fully traded.

03/04/2025

GMT Eight

SKB BIO-B (06990) announced that the company has received a filing notice from the China Securities Regulatory Commission regarding the implementation of full circulation of H shares with an issuance date of April 3, 2025. According to the filing notice, the company has completed the filing with the China Securities Regulatory Commission for the full circulation of H shares for a total of 25,421,200 domestic shares.

YIDA CHINA (03639) announced a net loss of 1.695 billion yuan attributable to shareholders in 2023, an increase of 130.07% year-on-year.

OOIL (00316) appoints Pan Zhigang as Chief Financial Officer.

Contact: [email protected]

SKB BIO-B(06990): The China Securities Regulatory Commission has issued a filing notice for the company's H shares to be fully traded.

RECOMMEND

CITIC SEC: TONGCHENGTRAVEL (00780) acquires Wanda Hotels & Resorts in its entirety, maintains "buy" rating.

Guosen: The transformation of bank wealth management from "deposits-like" to "multi-asset"

In April, the LPR remains unchanged. It is expected that the policy rate cut in the second quarter will drive down the LPR. There is room for a reduction in mortgage rates this year.